Published in Healthcare Finance, Tax and Law Weekly, February 7th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Research and Markets.
Report 1: Research and Markets has released Espicom Business Intelligence's "CNS Drug Discoveries: Neurodegenerative Disorders" chapter, which is part of CNS Drug Discoveries and focuses on the Alzheimer disease and Parkinson disease sectors of the market for neurodegenerative drugs.
Approximately US$6.6 billion was spent in 2005 on the symptomatic treatment of Alzheimer disease (AD) and Parkinson disease (PD). Although these...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.